Lakhno Yu., Andreishyna D., Derba K., Zhuk S., Zakhurdaieva L.
Department of obstetrics, gynecology and fetal medicine
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
Toufik’s Medical Journal
Volume 1, Supplement 1, November 2021
Abstract from Biomedical Perspectives III
Aim: To evaluate the effectiveness of the medication «Gynodek» in labor as prevention of obstetric trauma and antiseptic regenerative and regulatory effect in the postpartum period.
Methods and materials: Pro- and retrospective analysis of pregnancy and childbirth histories, statistical analysis of maternal and neonatal birth injuries with and without the use of «Gynodek». There were 500 women in labor who took part in the study. The first group (250 women) included women who used the drug «Gynodek» in childbirth an the postpartum period. The second group (250 women) consisted of those who did not use «Gynodek».
Conclusions: 1.In the first group of 250 parturient women, 109 cases of traumatization of women in childbirth were identified, In the second group: out of 250 parturient women, 144 cases .The injury rate was 43,6% in the first group, and 57.6% in the second group.
2. In the first group of women, the duration of the second stage of labor averaged 40 ± 10 minutes. In group II-was 50 ± 10 minutes.
3. due to the shortening the duration of the second stage of labor, higher Apgar scores were detected in newborns at 1 and 5 minutes of life in the first group compared to the second. In group I these scores were 7 ± 2 points at the first minute and 9 ± 1 point at 5 minutes of life. In group II these scores were 6 ± 2 points and 8 ± 1 point, respectively.
4. In the first group 73 parturient women with inflammatory smear type were found, in the second group the number was 88 women. In the first group, the objective symptomatology of inflammatory vaginitis in the postpartum period was decreased.
5. Subjective reduction of burning, irritation, and afterbirth pain in the first group was reported by 183 women (73.2%), and by 117 women(46.8%) in the second group. The use of the drug «Gynodek» reduces the rate of maternal and fetus trauma, shortens the duration of the active pushing phase, increases the assessment of newborns on the Apgar scale, reduces the duration, and eases the subjective esthesia of women in labor with inflammatory diseases of the genital tract after childbirth, collectively, it minimizes the length of stay in hospital for mother and child.